| scholarly article | Q13442814 |
| P50 | author | Mei-Ru Chen | Q56775177 |
| P2093 | author name string | Mei-Ru Chen | |
| P2860 | cites work | Environmental risk factors for multiple sclerosis. Part I: The role of infection | Q22252937 |
| Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1 | Q24562170 | ||
| EBV promotes human CD8 NKT cell development | Q27314724 | ||
| The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997 | Q28143029 | ||
| Multiple sclerosis | Q28299151 | ||
| Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme | Q29547201 | ||
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation | Q33599648 | ||
| Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs. | Q33976170 | ||
| Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus | Q33993288 | ||
| Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. | Q34250209 | ||
| Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis | Q34557923 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| Epstein-Barr virus: exploiting the immune system | Q34572150 | ||
| Epstein-Barr virus in autoimmune diseases | Q34887020 | ||
| Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. | Q35122260 | ||
| Persistence of the Epstein-Barr virus and the origins of associated lymphomas | Q35715171 | ||
| Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development | Q35888216 | ||
| Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain | Q36229219 | ||
| Spectrum of Epstein-Barr virus-associated diseases | Q37014791 | ||
| Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. | Q37016499 | ||
| NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis | Q37102921 | ||
| The curious case of the tumour virus: 50 years of Burkitt's lymphoma | Q37325443 | ||
| Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. | Q37381691 | ||
| Raising the NKT cell family | Q37688877 | ||
| EBV-induced human CD8(+) NKT cells synergise CD4(+) NKT cells suppressing EBV-associated tumours upon induction of Th1-bias | Q37729670 | ||
| EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. | Q38304806 | ||
| Early events in Epstein-Barr virus infection provide a model for B cell activation | Q42937446 | ||
| Long-term loss of canonical NKT cells following an acute virus infection | Q43996244 | ||
| Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals | Q44664210 | ||
| EBV in MS: guilty by association? | Q44927241 | ||
| Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis | Q45373213 | ||
| Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure | Q45737398 | ||
| AID is required for germinal center-derived lymphomagenesis | Q46861217 | ||
| EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies. | Q54461022 | ||
| Turning over the Chance card on MS susceptibility | Q84441699 | ||
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 5 | |
| P577 | publication date | 2011-01-26 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Epstein-barr virus, the immune system, and associated diseases | |
| P478 | volume | 2 |
| Q36871610 | A case of non-paraneoplastic anti-N-methyl d-aspartate receptor encephalitis presenting as a neuropsychiatric disorder |
| Q38666931 | Association of clinical and serological parameters of Systemic Lupus Erythematosus patients with Epstein-Barr virus antibody profile. |
| Q40777521 | CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient |
| Q59335149 | CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors |
| Q42123554 | Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells |
| Q35075193 | EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitis |
| Q89551910 | Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes |
| Q27022706 | Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection |
| Q36240353 | High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7 |
| Q55265317 | Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease. |
| Q92030460 | Importance of the immune system in head and neck cancer |
| Q56476000 | Interaction of viral oncogenic proteins with the Wnt signaling pathway |
| Q35645903 | Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs |
| Q36187673 | Microbes-induced EMT at the crossroad of inflammation and cancer |
| Q36872907 | Morbidity of solid cancer in Behςet's disease: analysis of 11 cases in a series of 506 patients |
| Q59358045 | Phylogenetic comparison of Epstein-Barr virus genomes |
| Q26798038 | Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment |
| Q36146934 | Prevalence of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in south-eastern Poland |
| Q47304703 | RNA2DMut: A web tool for the design and analysis of RNA structure mutations |
| Q38437452 | Regulatory network analysis of Epstein-Barr virus identifies functional modules and hub genes involved in infectious mononucleosis |
| Q39019130 | Role of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells |
| Q41863172 | Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia |
| Q28073937 | The concept of immune surveillance against tumors. The first theories |
| Q54244413 | The use of humanized mice for studies of viral pathogenesis and immunity. |
| Q34534640 | VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type |
| Q38622432 | Viral O-GalNAc peptide epitopes: a novel potential target in viral envelope glycoproteins. |
Search more.